BUSINESS Glenmark unveils ISB 2301, a groundbreaking multispecific immune activator for solid tumours 4:23 PM IST
BUSINESS Glenmark Pharmaceuticals receives U.S. FDA approval for progesterone vaginal inserts Apr 9, 2026
Glenmark Pharmaceuticals shares in focus as company launches Travoprost Ophthalmic Solution in U.S. Nov 27, 2024
Glenmark Pharmaceuticals’ market cap decreases by Rs 920 crore as shares drop 2.13% today – Know More Nov 18, 2024
Glenmark Pharmaceuticals shares surge nearly 2% as Ichnos Glenmark Innovation reports promising Phase 1 results for trispecific antibody ISB 2001 in relapsed multiple myeloma Nov 6, 2024
Glenmark Pharma shares surge over 6% today as Investec initiates ‘FAST Long’, expects 17% upside Sep 23, 2024